Adial Pharmaceuticals Adjourns Votes Pending Nasdaq Listing Approval
Adial Pharmaceuticals has adjourned votes on four proposals due to pending Nasdaq listing approval. The meeting has been reconvened for October 15, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.